EGNACARE-PLUS
Each Film Coated Tablet Contains: L-5 Methyltetrahydrofalate 1000mcg Excipients q.s.
| Composition | Each Film Coated Tablet Contains: L-5 Methyltetrahydrofalate 1000mcg Excipients q.s. |
| Packing | ALU ALU - 10*10 |
| MRP | ₹38 |
Product Overview
EGNACARE-PLUS is an advanced, biologically active folate supplement featuring 1000mcg of L-5-Methyltetrahydrofolate (L-methylfolate). Unlike standard folic acid, it bypasses complex enzymatic steps, offering immediate bioavailability for vital cellular processes and red blood cell production. It is highly valued in gynaecology, neurology, and psychiatry sectors, making it a lucrative specialty addition for pharma distributors.
Indications
EGNACARE-PLUS is clinically indicated for:
- MTHFR Polymorphism Management: Supplying active folate to individuals who cannot metabolize regular synthetic folic acid.
- Hyperhomocysteine Management: Reducing elevated cardiovascular and neurological risks by lowering blood homocysteine levels.
- Prenatal Nutritional Care: Lowering the incidence of neural tube defects (NTDs) during early fetal development.
- Adjunctive Mood Management: Enhancing therapeutic outcomes when combined with standard antidepressant regimens for major depressive disorder.
Dosage & Administration
Adults: 1 tablet daily, taken with or without food, or as directed by an obstetrician or healthcare professional.
Adverse Effects
This endogenous molecule is extremely well tolerated. Rare side effects may include:
- Mild gastrointestinal disturbances or gas
- Allergic skin rash (infrequent)
- Sleep pattern shifts or mild irritability at high doses
View Complete Medical Information
Contraindications
Contraindicated in patients with a history of hypersensitivity to L-methylfolate or any component excipients. Do not use as a standalone therapy for undiagnosed pernicious or vitamin B12-deficiency anemia, as folate can mask underlying neurological issues.
Warnings & Precautions
Before initiating therapy, evaluate Vitamin B12 levels to avoid masking potential macrocytic anemias. Dosage adjustments should be monitored carefully in patients with a history of convulsive disorders.
Drug Interactions
High doses may reduce the serum concentrations of anticonvulsant medications (such as phenytoin, fosphenytoin, and phenobarbital). Antifolate agents (like methotrexate or pyrimethamine) can interfere with folate activity.
Storage Instructions
Store below 30°C in a dry place. Protect from excessive light, heat, and moisture exposure.
Product image not available
Request This Product
- WHO-GMP Certified Formulations
- Monopoly Rights Available
- Get bulk pricing & MOQ
+91 9689237122 · replies within hours
Related Products
More products in the HAEMATINIC therapeutic category
HEMCYTE
Each 5ml Contains:Ext. Papaya(Lf) (Carica papaya) 1200 mgExt. Madhukparni (Lf) (Centella asiatica) 400 mgExt.Aloe Vera(Lf) (Aloe Vera) 200 mg Ext.Anwla(Fr) (Phyllanthus em
pet bottle with measuring cap & outer carton - 100ml
HEM ROSE-XT (NEW)
Each tablet contains: Ferrous Ascorbate Eq. to Elemental Iron 100mg Folic Acid 1.5mg Zinc 61.8mg
ALU ALU - 10*10 tablets
ASCOCI XT SYP
Each 5 ml Contains : Ferrous Ascorbate IP Eq To Elemental Iron 30 mg Folic Acid IP 1.5 mg Flavoured Syrupy Base q.s.
OUTER CARTON WITH M.C. - 150 ML
Interested in this product?
Contact our team to discuss PCD franchise, bulk orders, or contract manufacturing for your market.